
Accelerating the speed that healing reaches those in need
EVQLV is an AI-driven biotechnology company that leverages machine learning and computational biology to accelerate the discovery and development of therapeutic antibodies. Its HyperBind2 platform enables multi-shot learning for progressive antibody optimization, and its Abtique product makes AI-powered antibody discovery accessible to pharma and biotech partners at the discovery stage.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account